inherited disease susceptibility
MONDO:0020573
A latent susceptibility to disease at the genetic level, which may be activated under certain conditions.
Research intelligence
Directly mapped studies only · unique clinical trialsCurrent registry observations. Phase counts may overlap. Study start dates are not registry registration dates. Investigational interventions are not approved-treatment recommendations.
Medications under investigation
Verified disease and drug mappings that co-occur within the same study; not evidence of effectiveness.
MONDO disease family
Recruiting studies by city
Trial status
Trial phase
Study start year
Investigated drug interventions
Genetic predisposition
Genetic predisposition refers to a genetic characteristic which influences the possible phenotypic development of an individual organism within a species or population under the influence of environmental conditions. The term genetic susceptibility is often used synonymously with genetic predisposition and is further defined as the inherited risk for specific conditions, based on genetic variants. While environmental factors can influence disease onset, genetic predisposition plays a role in inherited risk of conditions, such as various cancers. At the molecular level, genetic predisposition often involves specific gene mutation, regulatory pathways, or epigenetic modifications that alter cellular processes, increasing disease risk.
Background only. Canonical identity remains MONDO; clinical-trial relationships come from ClinicalTrials.gov.Drugs being studied
Disease identity and terminology: MONDO. Trial relationships: ClinicalTrials.gov.